Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Rise Gold Corp.RYES · Entity 7717 | Director · 10% owner | November 20, 2025 | November 25, 2025 |
| Star Gold Corp.SRGZ · Entity 7542 | 10% owner | July 31, 2026 | September 15, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Rise Gold Corp.
Report date November 20, 2025 · Filed November 25, 2025
Jointly reported with Myrmikan Gold Fund, LLC, Myrmikan Capital, LLC
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $0.18 · Expires 2030-11-20 | Direct | 1,000,000 |
Reported balance
After 2025-11-20 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-11-20 · Grant · Acquired 1,000,000 · Balance 1,000,000 |
| OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $0.25 · Expires 2030-10-30 | Direct | 300,000 |
Reported balance
Holding disclosure · report date 2025-11-20 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 300,000 |
| OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $0.10 · Expires 2030-05-22 | Direct | 200,000 |
Reported balance
Holding disclosure · report date 2025-11-20 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 200,000 |
| OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $0.10 · Expires 2030-03-25 | Direct | 60,000 |
Reported balance
Holding disclosure · report date 2025-11-20 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 60,000 |
| OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $0.17 · Expires 2029-05-01 | Direct | 15,000 |
Reported balance
Holding disclosure · report date 2025-11-20 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 15,000 |
| OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $0.25 · Expires 2028-12-12 | Direct | 200,000 |
Reported balance
Holding disclosure · report date 2025-11-20 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 200,000 |
| OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $0.26 · Expires 2028-09-22 | Direct | 94,070 |
Reported balance
Holding disclosure · report date 2025-11-20 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 94,070 |
| Common StockSEC Table I · non-derivative | Direct | 1,210,653 |
Reported balance
Holding disclosure · report date 2025-11-20 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 1,210,653 |
| Common StockSEC Table I · non-derivative | IndirectBy Myrmikan Gold Fund, LLC | 14,663,191 |
Reported balance
Holding disclosure · report date 2025-11-20 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 14,663,191 |
| WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $0.15 · Expires 2028-05-08 | Direct | 304,800 |
Reported balance
Holding disclosure · report date 2025-11-20 · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · Balance 304,800 F1: The holder and the issuer have entered into a warrant standstill agreement dated 4-9-24, as amended and restated on May 8, 2025 with respect to Mr. Oliver and October 24, 2025 with respect to the Fund, pursuant to which the holder has agreed not to exercise these warrants. The agreement will remain in effect until terminated upon 61 days' written notice to the issuer from the holder. On that basis, the holder does not beneficially own the shares of common stock underlying the warrants, as defined for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. |
| WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $0.12 · Expires 2028-09-12 | Direct | 340,000 |
Reported balance
Holding disclosure · report date 2025-11-20 · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · Balance 340,000 F1: The holder and the issuer have entered into a warrant standstill agreement dated 4-9-24, as amended and restated on May 8, 2025 with respect to Mr. Oliver and October 24, 2025 with respect to the Fund, pursuant to which the holder has agreed not to exercise these warrants. The agreement will remain in effect until terminated upon 61 days' written notice to the issuer from the holder. On that basis, the holder does not beneficially own the shares of common stock underlying the warrants, as defined for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. |
| WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $0.16 · Expires 2027-04-29 | Direct | 210,526 |
Reported balance
Holding disclosure · report date 2025-11-20 · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · Balance 210,526 F1: The holder and the issuer have entered into a warrant standstill agreement dated 4-9-24, as amended and restated on May 8, 2025 with respect to Mr. Oliver and October 24, 2025 with respect to the Fund, pursuant to which the holder has agreed not to exercise these warrants. The agreement will remain in effect until terminated upon 61 days' written notice to the issuer from the holder. On that basis, the holder does not beneficially own the shares of common stock underlying the warrants, as defined for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. |
| WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $0.16 · Expires 2027-04-29 | Direct | 90,000 |
Reported balance
Holding disclosure · report date 2025-11-20 · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · Balance 90,000 F1: The holder and the issuer have entered into a warrant standstill agreement dated 4-9-24, as amended and restated on May 8, 2025 with respect to Mr. Oliver and October 24, 2025 with respect to the Fund, pursuant to which the holder has agreed not to exercise these warrants. The agreement will remain in effect until terminated upon 61 days' written notice to the issuer from the holder. On that basis, the holder does not beneficially own the shares of common stock underlying the warrants, as defined for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. |
| WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $0.45 · Expires 2028-10-24 | IndirectBy Myrmikan Gold Fund, LLC | 1,000,000 |
Reported balance
Holding disclosure · report date 2025-11-20 · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · Balance 1,000,000 F1: The holder and the issuer have entered into a warrant standstill agreement dated 4-9-24, as amended and restated on May 8, 2025 with respect to Mr. Oliver and October 24, 2025 with respect to the Fund, pursuant to which the holder has agreed not to exercise these warrants. The agreement will remain in effect until terminated upon 61 days' written notice to the issuer from the holder. On that basis, the holder does not beneficially own the shares of common stock underlying the warrants, as defined for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. |
| WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $0.15 · Expires 2028-05-08 | IndirectBy Myrmikan Gold Fund, LLC | 3,245,171 |
Reported balance
Holding disclosure · report date 2025-11-20 · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · Balance 3,245,171 F1: The holder and the issuer have entered into a warrant standstill agreement dated 4-9-24, as amended and restated on May 8, 2025 with respect to Mr. Oliver and October 24, 2025 with respect to the Fund, pursuant to which the holder has agreed not to exercise these warrants. The agreement will remain in effect until terminated upon 61 days' written notice to the issuer from the holder. On that basis, the holder does not beneficially own the shares of common stock underlying the warrants, as defined for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. |
| WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $0.17 · Expires 2028-10-10 | IndirectBy Myrmikan Gold Fund, LLC | 2,882,514 |
Reported balance
Holding disclosure · report date 2025-11-20 · row 16
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 16 · Balance 2,882,514 F1: The holder and the issuer have entered into a warrant standstill agreement dated 4-9-24, as amended and restated on May 8, 2025 with respect to Mr. Oliver and October 24, 2025 with respect to the Fund, pursuant to which the holder has agreed not to exercise these warrants. The agreement will remain in effect until terminated upon 61 days' written notice to the issuer from the holder. On that basis, the holder does not beneficially own the shares of common stock underlying the warrants, as defined for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. F2: These warrants were issued in connection with a secured loan agreement pursuant to which the holder loaned $500,000 to the issuer. |
| WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $0.16 · Expires 2027-04-09 | IndirectBy Myrmikan Gold Fund, LLC | 1,350,000 |
Reported balance
Holding disclosure · report date 2025-11-20 · row 17
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 17 · Balance 1,350,000 F1: The holder and the issuer have entered into a warrant standstill agreement dated 4-9-24, as amended and restated on May 8, 2025 with respect to Mr. Oliver and October 24, 2025 with respect to the Fund, pursuant to which the holder has agreed not to exercise these warrants. The agreement will remain in effect until terminated upon 61 days' written notice to the issuer from the holder. On that basis, the holder does not beneficially own the shares of common stock underlying the warrants, as defined for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. |
| WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $0.26 · Expires 2025-12-07 | IndirectBy Myrmikan Gold Fund, LLC | 140,000 |
Reported balance
Holding disclosure · report date 2025-11-20 · row 18
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 18 · Balance 140,000 F1: The holder and the issuer have entered into a warrant standstill agreement dated 4-9-24, as amended and restated on May 8, 2025 with respect to Mr. Oliver and October 24, 2025 with respect to the Fund, pursuant to which the holder has agreed not to exercise these warrants. The agreement will remain in effect until terminated upon 61 days' written notice to the issuer from the holder. On that basis, the holder does not beneficially own the shares of common stock underlying the warrants, as defined for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. |
| Deferred Share Units (DSUs)SEC Table II · derivative / convertible security | Direct | 365,854 |
Reported balance
Holding disclosure · report date 2025-11-20 · row 19
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 19 · Balance 365,854 F3: The reporting person is entitled to receive one share of the issuer's Common Stock for each DSU held upon ceasing to be an Eligible Person as defined in the issuer's Long-Term Incentive Plan. "Eligible Person" means a Director, Officer, Employee, Management Company Employee, or Consultant of the Issuer or a subsidiary of the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: The holder and the issuer have entered into a warrant standstill agreement dated 4-9-24, as amended and restated on May 8, 2025 with respect to Mr. Oliver and October 24, 2025 with respect to the Fund, pursuant to which the holder has agreed not to exercise these warrants. The agreement will remain in effect until terminated upon 61 days' written notice to the issuer from the holder. On that basis, the holder does not beneficially own the shares of common stock underlying the warrants, as defined for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended.
F2: These warrants were issued in connection with a secured loan agreement pursuant to which the holder loaned $500,000 to the issuer.
F3: The reporting person is entitled to receive one share of the issuer's Common Stock for each DSU held upon ceasing to be an Eligible Person as defined in the issuer's Long-Term Incentive Plan. "Eligible Person" means a Director, Officer, Employee, Management Company Employee, or Consultant of the Issuer or a subsidiary of the Issuer.
Star Gold Corp.
Report date July 31, 2026 · Filed September 15, 2026
Jointly reported with Myrmikan Capital, LLC, Myrmikan Gold Fund, LLC
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 31,976,707 |
Reported balance
After 2026-07-31 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2026-07-31 · Exercise / conversion · Acquired 5,000,000 · Balance 31,976,707 |
| WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $0.08 · Expires 2027-02-26 | Direct | 5,000,000 |
Reported balance
After 2026-07-31 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-07-31 · Exercise / conversion · Disposed 5,000,000 · Balance 5,000,000 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 09, 2022 Filed Mar 10, 2023 20:14 UTC | Rise Gold Corp. RYES · Entity 7717 | SaleCommon Stock | 10,000 | $0.71 | $7,100.00 |
DisclosureSEC source: 0001727689-23-000013 · ownership.xml · nonDerivative · entry 1 Oliver Daniel Jr · CIK 0001965660 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Myrmikan Gold Fund, LLC Disclosed balance after: 2,349,849 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.